Washington Trust Advisors’s NeoGenomics NEO Stock Holding History

Washington Trust Advisors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-160	Closed	-$1.24K	–	657
2025 Q3	$1.24K	Sell	160 -134	-46%	-$939	﹤0.01%	674
2025 Q2	$2.15K	Hold	294	–	–	﹤0.01%	610
2025 Q1	$2.79K	Hold	294	–	–	﹤0.01%	591
2024 Q4	$4.84K	Hold	294	–	–	﹤0.01%	575
2024 Q3	$4.34K	Hold	294	–	–	﹤0.01%	592
2024 Q2	$4.08K	Hold	294	–	–	﹤0.01%	586
2024 Q1	$4.62K	Buy	294 +90	+44%	+$1.39K	﹤0.01%	584
2023 Q4	$3.3K	Hold	204	–	–	﹤0.01%	618
2023 Q3	$2.51K	Hold	204	–	–	﹤0.01%	627
2023 Q2	$3.28K	Hold	204	–	–	﹤0.01%	590
2023 Q1	$3.55K	Hold	204	–	–	﹤0.01%	665
2022 Q4	$1.89K	Hold	204	–	–	﹤0.01%	728
2022 Q3	$2K	Hold	204	–	–	﹤0.01%	859
2022 Q2	$2K	Hold	204	–	–	﹤0.01%	888
2022 Q1	$2K	Hold	204	–	–	﹤0.01%	956
2021 Q4	$7K	Buy	+204	New	+$7.99K	﹤0.01%	792

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Washington Trust Advisors's NEO Position: Q4 2025 in Review

Washington Trust Advisors sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 160 shares — an estimated $1.24K sold.

Washington Trust Advisors first reported a position in NEO in Q4 2021 and held it in 16 quarters. The position peaked at $7K in Q4 2021. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

Washington Trust Advisors reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
Washington Trust Advisors sold 160 NeoGenomics shares in Q4 2025, an estimated $1.24K.
Washington Trust Advisors first reported a position in NeoGenomics in Q4 2021 and held it in 16 quarters.
Washington Trust Advisors's NeoGenomics position peaked at $7K in Q4 2021.
256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Washington Trust Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.